Rob Magin

Rob Magin, PhD

Associate Scientific Director

Rob Magin joined the Mark Foundation as an Associate Scientific Director in May 2021. He came to the Mark Foundation from the Dana-Farber Cancer Institute in Boston, where he conducted his post-doctoral research as part of a collaborative team developing first-in-class inhibitors against deubiquitinating enzymes. Prior to this, Rob received his PhD in Biochemistry and Molecular Biophysics from the University of Pennsylvania, and a BA in Biology from Northwestern University, where his research projects integrated biochemistry, structural biology, and chemical biology.

View more team members